Florida Gov. Ron DeSantis has vowed to fight a decision from federal health regulators to block two coronavirus antibody treatments after the drugs were found to be ineffective against treating the widespread omicron variant.

The Associated Press is calling on Florida Gov. Ron DeSantis to end “harassing behavior” by one of his press aides against an AP reporter who received threats and other online abuse.

Florida Gov. Ron DeSantis has been criticized for efforts to ban mask mandates and vaccine passports.

Paycom Software’s Chad Richison and Advanced Micro Devices’ Lisa Su are among the top paid CEOs in the S&P 500 index.

After being diagnosed and treated for the coronavirus, President Donald Trump posted a nearly 5-minute video to Twitter on Wednesday evening. The president spent four days at Walter Reed Medical Center, where he received the drug Regeneron, which he said made him “feel good immediately.”A MESSAGE FROM THE PRESIDENT! pic.twitter.com/uhLIcknAjT — Donald J. Trump (@realDonaldTrump) October 7, 2020The president said he’s working to provide access to Regeneron to those diagnosed with the coronavirus for free. “For me, I walked in, I didn’t feel good. I want everybody to be given the same treatment as your president because I feel great.

(AP Photo/Evan Vucci)WASHINGTON – President Donald Trump on Wednesday credited an experimental drug treatment with helping his recovery from COVID-19 and suggested his diagnosis could be a “blessing in disguise" in the nation's battle against the pandemic. In a new White House video posted Wednesday evening, Trump said his illness had shed light on an experimental antibody cocktail that he tied to his improved condition. The White House has released only limited details about his condition and treatment, leading to questions about what lies ahead for Trump. Access to Trump for White House aides has been extremely limited since his discharge. He also thanked a supporter who tweeted she “would wade though a sea of COVID infested water to vote for President Trump on November 3rd."